Figure 3From: De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancerCirculating miR-122 predicts metastatic relapse in an independent BC cohort. Levels of serum miR-122 in an independent validation cohort of 26 stage II-III BC patients were measured by PCR and normalized to the level of miR-16 in each sample.Back to article page